|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/343 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/343 | (2013.01) | ||
| A61P 25/24 | (2006.01) | ||
| A61P 25/24 | (2018.01) |
| (11) | Patento numeris | 3661494 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18755664.2 |
| Europos patento paraiškos padavimo data | 2018-08-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-06-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-10-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2018/044995 |
| Data | 2018-08-02 |
| (87) | Numeris | WO 2019/028245 |
| Data | 2019-02-07 |
| (30) | Numeris | Data | Šalis |
| 201762540200 P | 2017-08-02 | US |
| (72) |
POLYMEROPOULOS, Mihael , US
POLYMEROPOULOS, Christos , US
XIAO, Changfu , US
|
| (73) |
Vanda Pharmaceuticals Inc. ,
2200 Pennsylvania Avenue NW
Suite 300-E, Washington, DC 20037,
US
|
| (54) | USE OF TASIMELTEON FOR THE TREATMENT OF AFFECTIVE DISORDERS IN MAJORITY BLACK AFRICAN PATIENTS |
| USE OF TASIMELTEON FOR THE TREATMENT OF AFFECTIVE DISORDERS IN MAJORITY BLACK AFRICAN PATIENTS |